|
|
Other links at Articles > Orthopedics |
| 4. |
New Thrombin Inhibitor Superior to Enoxaparin for Thromboprophylaxis
|
|
|
The investigational oral direct thrombin inhibitor rivaroxaban (BAY 59-7939, Bayer HealthCare, Leverkusen, Germany) is "significantly more effective" than enoxaparin for preventing embolic complications after orthopedic surgery, according to a presentation on Sunday at the 49th annual meeting of the American Society of Hematology in Atlanta. Reuters Health Information
|
|
|